Spots Global Cancer Trial Database for GI Complications in Cancer Immunotherapy Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: GI Complications in Cancer Immunotherapy Patients

Official Title: GI Complications in Cancer Immunotherapy Patients

Study ID: NCT02784366

Conditions

Malignant Melanoma

Interventions

Study Description

Brief Summary: The purpose of this study is to establish a prospective observational cohort of cancer immunotherapy patients with GI side effects in order to identify biomarkers that predict GI complications due to treatment.

Detailed Description: Primary objective * To create a data and bio-specimen repository to enhance both safety and efficacy of immunotherapy Secondary objective * Identify biomarkers that may predict GI toxicity in cancer patients undergoing immunotherapy * Define the clinical course of intestinal inflammation and identify genetic factors of therapeutic response to GI medications * Analyze genotype-phenotype correlations in GI side effects in patients undergoing cancer immunotherapy